News for Valneva SE (0OB3.L)

Published at

Mar 5, 2025 2:00 AM

by gurufocus.com

positive

positive

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN

PR NewswireNEW YORK, March 4, 2025 NEW YORK, March 4, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Valneva SE ("Val

VLA.PA INRLF 0OB3.L

Read more →
Published at

Mar 3, 2025 7:23 AM

by manilatimes.net

positive

positive

Valneva to Present at Upcoming TD Cowen and Van Lanschot Kempen Healthcare Investor Conferences

**media[554956]**

VLA.PA INRLF COWNL COWN 0OB3.L

Read more →
Published at

Feb 28, 2025 5:52 PM

by manilatimes.net

neutral

neutral

Valneva Receives EMA's Positive CHMP Opinion for Adolescent Label Extension for Chikungunya Vaccine IXCHIQ®

**media[553770]**

VLA.PA INRLF 0OB3.L

Read more →
Published at

Feb 18, 2025 2:52 PM

by rttnews.com

mixed

mixed

U.S. Stocks May Add To Last Week's Strong Gains In Early Trading

The major U.S. index futures are currently pointing to a higher open on Tuesday, with stocks likely to move to the upside as trading resumes following the Presidents' Day holiday on Monday.

VLA.PA INRLF 0OB3.L NZX.NZ BPT.AX CTS

Read more →
Published at

Feb 18, 2025 10:14 AM

by rttnews.com

positive

positive

European Shares Slip Into Red After Positive Start

European stocks slipped into the red on Tuesday after opening on a firm note earlier amid Ukraine war developments. The U.K. unemployment rate remained unchanged at 4.

VLA.PA INRLF 0OB3.L

Read more →
Published at

Feb 18, 2025 7:23 AM

by manilatimes.net

positive

positive

Valneva Reports Preliminary Unaudited 2024 Revenue and Cash and Provides 2025 Outlook

**media[542807]**

VLA.PA INRLF 0OB3.L

Read more →
Published at

Feb 6, 2025 6:25 PM

by manilatimes.net

neutral

neutral

Shareholding declaration Valneva SE - January 2025

**media[534432]**

VLA.PA INRLF 0OB3.L

Read more →
Published at

Feb 5, 2025 7:24 AM

by manilatimes.net

positive

positive

Valneva Receives Marketing Authorization in the UK for the World's First Chikungunya Vaccine, IXCHIQ®

**media[532401]**

VLA.PA INRLF 0OB3.L

Read more →
Published at

Jan 30, 2025 5:52 PM

by manilatimes.net

positive

positive

Valneva Announces New IXIARO® Supply Contract with the U.S. Government Worth a Minimum of $32.8 Million

**media[528389]**

VLA.PA INRLF 0OB3.L

Read more →
Published at

Jan 22, 2025 5:55 PM

by manilatimes.net

positive

positive

Valneva Reports Positive Phase 2 Results in Children for its Chikungunya Vaccine and Announces Phase 3 Dose Decision

**media[521860]**

VLA.PA INRLF 0OB3.L

Read more →
Published at

Jan 20, 2025 5:56 PM

by manilatimes.net

positive

positive

Valneva Reports High Sustained Immune Response in Adolescents One Year After Single Vaccination with its Chikungunya Vaccine

**media[519621]**

VLA.PA INRLF 0OB3.L

Read more →
Published at

Jan 6, 2025 6:06 PM

by manilatimes.net

neutral

neutral

Valneva to Meet with Investors during the J.P. Morgan Healthcare Conference

**media[507231]**

VLA.PA INRLF 0OB3.L

Read more →
Published at

Dec 19, 2024 4:49 PM

by benzinga.com

mixed

mixed

Accenture Posts Upbeat Results, Joins Darden Restaurants, CarMax And Other Big Stocks Moving Higher On Thursday - Darden Restaurants (NYSE:DRI), Accenture (NYSE:ACN)

U.S. stocks were higher, with the Dow Jones index gaining over 150 points on Thursday. Shares of Accenture plc ACN rose sharply in today's session after the co...

VLA.PA TRIP.MX TRIP.BA TRIP T6A.DE PRTA OMER MVST MSB.AX MESO MEOBF JWN.MX JWN J1WN34.SA INRLF INOD ACNN.MX ACN 0Y3M.L 0Y0Y.L 0QZS.L 0OB3.L 0KBU.L 0K8J.L KMX DRI DDN.DE 0I77.L 0HTQ.L

Read more →
Published at

Dec 19, 2024 8:21 AM

by manilatimes.net

positive

positive

Valneva Successfully Expands Access to Asia for its Chikungunya Vaccine with Serum Institute of India

**media[496293]**

VLA.PA INRLF 0OB3.L

Read more →
Published at

Dec 4, 2024 7:29 AM

by manilatimes.net

negative

negative

Valneva Announces Peer-Reviewed Publication on the Global Health and Economic Burden of Chikungunya in The British Medical Journal

**media[482870]**

VLA.PA INRLF 0OB3.L

Read more →
Published at

Dec 3, 2024 7:10 AM

by manilatimes.net

positive

positive

Valneva Reports Positive Three-Year Antibody Persistence Data for its Single-Shot Chikungunya Vaccine IXCHIQ®

**media[481543]**

VLA.PA INRLF 0OB3.L

Read more →
Published at

Nov 26, 2024 6:04 PM

by manilatimes.net

neutral

neutral

Valneva Submits Label Extension Application for its Chikungunya Vaccine, IXCHIQ®, to the U.S. FDA

**media[476984]**

VLA.PA INRLF 0OB3.L

Read more →
Published at

Nov 13, 2024 6:32 PM

by manilatimes.net

neutral

neutral

Valneva and LimmaTech Announce First Vaccination in Phase 2b Human Challenge Study of Tetravalent Shigella Vaccine Candidate S4V2

**media[465296]**

VLA.PA INRLF 0OB3.L

Read more →
Published at

Nov 12, 2024 7:29 AM

by manilatimes.net

positive

positive

Valneva to Present and Hold Investor Meetings at Upcoming U.S. and European Healthcare Conferences

**media[462801]**

VLA.PA INRLF 0OB3.L

Read more →
Published at

Sep 13, 2024 11:16 AM

by medium.com

mixed

mixed

U.S. Hepatitis B Vaccine Market 2024: Advances in Vaccine Formulations and Administration

As per Fortune Business Insights’ report, the U.S. hepatitis B vaccine Market share sector attained a worth of USD 2.49 Billion in 2022. Forecasts indicate a promising path, foreseeing a Compound…

VLA.PA VBIV SGIOY SGIOF MRKD.BA MRK.SN MRK.PA MRK.MX MRK INRLF 6MK.DE 4507.T 0OB3.L DVAX 0IDA.L

Read more →